Ultragenyx Pharmaceutical Inc.RARENASDAQ
LOADING
|||
Net Income Contraction
Below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-569.18M
↓ 49% below average
Average (9y)
$-381.78M
Historical baseline
Range
High:$-145.62M
Low:$-707.42M
CAGR
+16.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-569.18M | +6.2% |
| 2023 | $-606.64M | +14.2% |
| 2022 | $-707.42M | -55.8% |
| 2021 | $-454.02M | -143.4% |
| 2020 | $-186.57M | +53.7% |
| 2019 | $-402.73M | -103.8% |
| 2018 | $-197.61M | +34.6% |
| 2017 | $-302.14M | -22.9% |
| 2016 | $-245.87M | -68.8% |
| 2015 | $-145.62M | - |